Thomas J. Schall Immuneering Corp (IMRX) insider trading activity

IMRX Quotes by TradingView

Thomas J. Schall is Director of Immuneering Corp. Currently has a direct ownership of 74,530 shares of IMRX, which is worth approximately $476,992. The most recent transaction as insider was on Jan 15, 2026, when has been sold 21,645 shares (Class A Common Stock) at a price of $4.67 per share, resulting in proceeds of $101,082. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 74.5K
40.93% 3M change
2470.0% 12M change
Total Value Held $476,992

Thomas J. Schall Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 15 2026
BUY
Open market or private purchase
$101,082 $4.67 p/Share
21,645 Added 22.51%
74,530 Class A Common Stock
Jun 27 2025
BUY
Open market or private purchase
$34,770 $3.66 p/Share
9,500 Added 15.23%
52,885 Class A Common Stock
Jun 17 2025
BUY
Open market or private purchase
$89,471 $2.21 p/Share
40,485 Added 48.27%
43,385 Class A Common Stock
Mar 22 2024
BUY
Open market or private purchase
$7,394 $2.55 p/Share
2,900 Added 50.0%
2,900 Class A Common Stock

Also insider at

CCXI
ChemoCentryx, Inc.
President and CEO
TJS

Thomas J. Schall

Director
San Carlos, CA

Track Institutional and Insider Activities on IMRX

Follow Immuneering Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMRX shares.

Notify only if

Insider Trading

Get notified when an Immuneering Corp insider buys or sells IMRX shares.

Notify only if

News

Receive news related to Immuneering Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IMRX